AXIM Biotechnologies, Inc. (AXIM) shareholders
AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2024, quý kết thúc ngày Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Ownership
Who owns AXIM Biotechnologies's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Catalina Valencia President and Director, 10% owner | Jan 30, 2024 | Buy | +1,086,216 | – | – | 28,608,220 |
| Catalina Valencia 10% owner | Aug 24, 2022 | Buy | +3,861,004 | $0.03 | $115.83K | 23,661,004 |
| Blake Schroeder Director | Aug 22, 2022 | Conversion | +854,012 | $0.03 | $25.62K | 854,012 |
| John Walter Huemoeller Ii Chief Executive Officer, Director | Mar 19, 2020 | Buy | +6,000,000 | – | – | 6,000,000 |
| Robert Malasek CFO | Mar 21, 2018 | Award | +50,000 | – | – | 50,000 |
| Marijuana Inc Medical 10% owner | Dec 2, 2016 | Award | +7,200,000 | – | – | 22,669,125 |
| Marijuana Inc Medical 10% owner | Dec 2, 2016 | Award | +7,200,000 | – | – | 22,143,650 |
| Marijuana Inc Medical 10% owner | Nov 21, 2016 | Award | +500,000 | – | – | 500,000 |
| Lekhram Changoer Director, 10% owner | Nov 21, 2016 | Award | +240,000 | – | – | 2,265,000 |
| Lekhram Changoer Director, 10% owner | Nov 21, 2016 | Award | +500,000 | – | – | 500,000 |
| Lekhram Changoer Director, 10% owner | Nov 21, 2016 | Award | +2,000,000 | – | – | 2,265,000 |
| Marijuana Inc Medical 10% owner | Nov 21, 2016 | Award | +500,000 | – | – | 500,000 |
| George Anastassov CEO/Secretary, Director, 10% owner | Nov 21, 2016 | Award | +500,000 | – | – | 500,000 |
| George Anastassov CEO/Secretary, Director, 10% owner | Nov 21, 2016 | Award | +2,000,000 | – | – | 3,002,000 |
| George Anastassov CEO/Secretary, Director, 10% owner | Nov 21, 2016 | Award | +250,000 | – | – | 3,002,000 |
| George Anastassov President, Director, 10% owner | Feb 5, 2016 | Award | +125,000 | – | – | 15,365,650 |
| Lekhram Changoer Director, 10% owner | Dec 18, 2015 | Award | +25,000 | – | – | 25,000 |
| George Anastassov President, Director, 10% owner | Nov 9, 2015 | Award | +125,000 | – | – | 15,240,650 |
| George Anastassov President, Director, 10% owner | Jul 2, 2015 | Award | +500,000 | – | – | 15,240,650 |
| Lekhram Changoer Director, 10% owner | Apr 23, 2015 | Award | +1,000,000 | – | – | 1,500,000 |
| George Anastassov President, Director, 10% owner | Apr 23, 2015 | Award | +1,000,000 | – | – | 1,500,000 |
| George Anastassov President, Director, 10% owner | Feb 23, 2015 | Award | +2,000 | – | – | 14,945,650 |
| Rosemary Samuels PRESIDENT, CEO, CFO, Director, 10% owner | Mar 21, 2014 | Sale | −1,000,000 | $400.00 | $400.00M | 0 |
| Rosemary Samuels PRESIDENT, CEO, CFO, Director, 10% owner | Mar 21, 2014 | Sale | −20,000,000 | $8000.00 | $160.00B | 0 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-44.4%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of AXIM Biotechnologies's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
See a number that looks wrong?